Summary Increased generation of reactive oxygen species, coupled with impaired endogenous scavenging mechanisms, plays a prominent role in the aetiology of neurovascular abnormalities in experimental diabetes mellitus. We examined the efficacy of the natural anti-oxidants vitamins C, E and B-carotene in preventing nerve conduction and nutritive blood flow deficits in streptozotocin-diabetic rats. One month of diabetes caused a 19.1% reduction in sciatic motor conduction velocity (p < 0.001). This was approximately prevented 80-90% by high-dose (1000 mg. kg -1' day -1) vitamin E and B-carotene treatments (p < 0.001). Vitamin C had lesser effects; the maximum protection found for motor conduction velocity was 36 % using a dose of 150 mg. kg -1-day -1 (p <0.001). High dose (500 mg. kg -1 9 day -1) vitamin C had a lesser effect on conduction than intermediate doses. Joint vitamin C and lower dose (500 mg. kg -1. day -1) vitamin E treatment had a predominantly additive preventive effect against nerve dysfunction. Resistance to hypoxic conduction failure for sciatic nerve in vitro was markedly increased by diabetes and this remained relatively unaffected by treatment. Sciatic nutritive endoneurial blood flow, measured using microelectrode polarography and hydrogen clearance, was reduced 46.1% by 1 month of diabetes (p < 0.001). This was prevented to the extent of 87 %, 36 % and 98 % by vitamins E, C and [3-carotene, respectively (p < 0.01). These data emphasize the role of oxidative stress in the development of early neurovascular changes in experimental diabetes and show that naturally available scavengers have a neuroprotective action. [Diabetologia (1995[Diabetologia ( ) 38: 1285[Diabetologia ( -1294 Key words Neuropathy, nerve conduction, endoneurial blood flow, ischaemia, oxidative stress, vitamin C, vitamin E, [3-carotene, anti-oxidant, vascular endothelium, diabetic rat.
Increased activity of reactive oxygen species (ROS), coupled with a weakening of natural cellular protection mechanisms contributes to vascular dysfunction in diabetes mellitus [1] [2] [3] [4] . In normotensive subjects without evidence of microvascular complications, acute intravenous anti-oxidant administration caused a much greater hypotensive effect in diabetic than in non-diabetic individuals [5] , suggesting a widespread involvement of ROS-related mechanisms in the disrupted control of tone in the major vascular beds. A likely action of superoxide anions is to neutralize nitric oxide (NO), which causes a characteristic deficit in endothelium-dependent relaxation [6] [7] [8] [9] [10] . Recently, anti-oxidant treatment studies have led to the view that free radical activity is involved in the reduction in nutritive blood flow that causes peripheral nerve hypoxia and dysfunction in experimental models of diabetes [11] [12] [13] .
The main dietary sources of ROS scavengers include vitamins C (ascorbate) and E (D-a-tocopherol) and the precursor of vitamin A, B-carotene. Vitamin C content is depressed by diabetes, with a concomitant increase in dehydroascorbate [14] [15] [16] [17] .
Restriction of dietary vitamin E intake causes neuropathic changes in non-diabetic rats and exacerbates the nerve conduction velocity (NCV) deficit in diabetic rats [15] , "vitamin E is a lipophilic anti-oxidant that scavenges the most highly reactive and damaging of the ROS, the hydroxyl radical, and can stem the chain reaction of polyunsaturated fatty acidperoxidation in membranes [18] . This action may be aided by vitamin C, which can regenerate a-tocopherol from the tocopheroxyl radical, at least in vitro [19] . The primary action of [3-carotene against ROS is to quench excited singlet oxygen species [18] . The aim of this investigation was to assess the extent of protection against NCV and nutritive endoneurial blood flow defects afforded by vitamins C, E, and [3-carotene in streptozotocin-diabetic rats.
lis anterior muscle alone for study 2. Sensory NCV was measured in the saphenous nerve between the groin and ankle. Rectal and nerve temperatures were monitored, and regulated between 36.5 and 37.5 ~ Methods have previously been described in detail [20] .
In study 1, sciatic nerve resistance to hypoxic conduction failure was measured in vitro for nerves from the contralateral leg as previously described [21] . The sciatic trunk was removed and mounted on bipolar stimulating (proximal end) and recording (distal end) electrodes in a chamber containing Krebs-Ringer solution at 35 ~ with 5.5 mmol. 1-1 glucose for nerves from non-diabetic, and 40 mmol. 1-1 glucose for the diabetic rats. Bathing ftuid was gassed with 95 % 0 2 5 % CO 2. Nerves were equilibrated for 30 min, then the chamber was refilled with mineral oil pre=gassed for i h with 100 % N2. Nerves were stimulated with just supramaximal pulses (1 Hz, 0.05 ms width, 10 mA) and comPOund action potential amplitude was monitored at 2-min intervals until it fell below 10 % of its initial value.
Materials and methods
The experiments were performed in accordance with regulations specified in the United Kingdom "Animal Procedures Act, 1986" and the National Institutes of Health "Principles of Laboratory Animal Care, 1985 revised version".
Diabetes induction and experimental design. Male Sprague-
Dawley rats (Aberdeen University breeding colony), 19 weeks old at the start of the study were used. Non-diabetic animals acted as onset controls. Diabetes, induced by intraperitoneal administration of streptozotocin (Zeneca Pharmaceuticals, Macclesfield, Cheshire, UK) at 40-45 rag. kg -1 freshly dissolved in sterile 0.9 % NaC1 solution, was verified 24 h later by estimating hyperglycaemia and glycosuria (Visidex II and Diastix; Ames, Slough, UK). Diabetic rats were tested weekly and weighed daily. Animals were rejected if the plasma glucose concentration was more than 20 mmol. 1-1 or if body weight consistently increased over 3 days. Samples were taken from the tail vein or carotid artery after final experiments for plasma glucose determination (GOD-Perid method; Boehringer Mannheim, Mannheim, Germany).
The main experimental design involved treatment for i month, 2 days after diabetes was verified. Vitamin C (Lascorbic acid; Sigma, Poole, Dorset, UK) was given in the drinking water such that the dose was approximately 150 mg. kg -1 9 day -1. This dose was found to be maximally effective in a preliminary study which examined the dose-response relationship (treatment range 5-500 mg. kg -1. day -1) for motor and sensory NCV using a reversal paradigm of 2 weeks' treatment following 6 weeks of untreated diabetes. Vitamin E (mixed isomers approximately 68 % D-, 32 % L-a-tocopherol, from vegetable oil; Sigma) and [3-carotene (Sigma) were given as dietary supplements, the dose being approximately 1000 mg. kg -1 9 day -1. Further experiments studied the interaction between vitamin C (150 mg. kg -1 9 day -1) and vitamin E (500 mg. kg -1 -day -1) co-treatment on NCV. The vitamin E doseresponse relationship (100-1000 mg. kg -1 . day -1) was also determined for prevention of motor NCV deficits.
Nerve conduction velocity and resistance to hypoxic conduction failure. In final experiments (1.0-1.5 g. kg -1 urethane or 50-100 mg 9 kg -1 thiobutabarbital anaesthesia i. p.), NCV was measured in vivo between the sciatic notch and the knee for sciatic motor branches supplying tibialis anterior (peroneal division) and gastrocnemius (tibial division) muscles for study 1 or tibiaSciatic endoneurial blood flow. Rats were anaesthetized with thiobutabarbital (50-100 mg. kg -I i.p.). The trachea was cannulated for artificial ventilation and a carotid cannula was used to monitor mean systemic blood pressure. Sciatic endoneurial blood flow was measured using microelectrode polarography and hydrogen clearance as previously described [11, 22] . The hydrogen potardgraphy method was chosen because it has been widely used to measure flow in a variety of tissues over the past 40 years [reviewed in 23, 24] . It has the advantage of permitting the measuremem of nutritive (capillary) endoneurial blood flow which is crucial for neuronal function [6, 24] 6, 24] . One group, using a microsphere technique, has reported increased entrapment by vasa nervorum in diabetic rats. which was interpreted as increased blood flow [25] . However. this interpretation is only valid if the differences between diabetic and non-diabetic vasculature solely relate to flow, which is not the case [6] . In addition, the catch of microspheres by a small tissue (i. e. nerve tissue) is too low for accurate measurement [26] which probably accounts for a fivefold difference in reported putative resting nerve flow values between studies using this method in non-diabetic rats [25, 27] ; a level of variability that far exceeds the maximum physiological capacity to increase nerve blood flow above the resting value [24] . Thus, hydrogen clearance measurements in rats are likely to reflect accurately the state of endoneurial capillary perfusion and are, therefore, suitable for comparison with measures of nerve function.
Briefly, core temperature of the rat was monitored and regulated between 37 and 38 ~ using a rectal probe and radiant heat. The skin around the sciatic nerve incision was sutured to a metal ring and used to form a pool which was filled with mineral oil at 37 ~ to a depth of at least 1 cm to minimize gas diffusion. Rats were given neuromuscular blockade using D-tubocurarine (Sigma; 2 mg-kg -1 via the carotid cannula) and artificially ventilated. The level of anaesthesia was monitored by observing any reaction of blood pressure to manipulation, and supplementary anaesthetic was given as necessary. A glass-insulated platinum microelectrode (tip diameter 2-8 ~tm, 45 o bevel) was inserted into the middle portion of the sciatic nerve, above its trifurcation, and polarized at 0.25 V with respect to a subcutaneous reference electrode. H2 (10 %) was ad- Data are mean + SEM ded to the inspired gas, the proportions of O 2 and N 2 being adjusted to 20 and 70 %, respectively. When the H 2 current recorded by the electrode had stabilized (15-40 rain), indicating equilibrium with arterial blood, the H 2 supply was shut off and N2 delivery was increased appropriately. The H 2 clearance curve was recorded up to baseline (25-75 rain), the latter being defined as no systematic decline in electrode current over 5 rain. This procedure was then repeated at another nerve site. After the experiment, clearance curves were digitized and mono-exponential or bi-exponential curves were fitted to the data by computer using nonlinear regression software that employed the Marquardt algorithm and the least squares method for optimizing goodness-of-fit (Inplot; Graphpad, San Diego, Calif., USA). The slow exponent was taken to represent nutritive (capillary) flow [22, 23, 28] . Composite flow was calculated as the weighted sum of fast and slow exponents. Vascular conductance was determined by dividing flow by the mean arterial blood pressure during the recording period.
Statistical analysis
Unless otherwise stated, data were subjected to Bartlett's test for homogeneity of variances, and where necessary they were normalized by log transformation before being tested using one-way analysis of variance. When significance was attained (p < 0.05), between-group differences were established using the Student-Newman-Kenls multiple comparison test. All calculations were performed using a standard statistical software package (Instat; Graphpad). Data are expressed as mean + SEM. 
Results
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Effects of vitamin C and E treatment, alone and in combination, on sciatic motor (A) and saphenous sensory (B) conduction velocity in diabetic rats. NC, Non-diabetic control group (n= 10); D, 1month diabetic group (n= 9); VC, 1 month diabetic group treated with vitamin C (150 nagkg -1 . day -z) from diabetes induction (n = 9); VE5, i month diabetic group treated with vitamin E (500 mg. kg -1. day -1) from induction (n = 8); VE10, i month diabetic group treated with vitamin E (t000 mg. kg -1. day -1) from induction (n = 9); VEC, 1 month diabetic group treated with both vitamin C (150 mg-kg -I-day -1 ) and vitamin E (500 mgkg -1 -day 4) from induction (n = 9 (Fig. 1A ). Vitamin C, at a dose of 150 rag-kg -1, day -1, reduced the development of the NCV defcit to 12.3 + 0.4 % (p < 0.001), although there remained a significant difference compared to non-diabetic control values (p < 0.001). Vitamin E (500 rag. kg -a -day -a) approximately matched the effect of vitamin C (11.7 + 0.4 % deficit, p < 0.001) whereas a higher dose (1000 rag-kg -1-day -t) produced a more marked action, such that the motor NCV reduction was limited to 6.4 + 0.5 % (p < 0.001), although prevention remained incomplete compared to non-diabetic controls (p < 0.001). Combined treatment with vitamin C and the lower dose of vitamin E gave a greater degree of protection than either component alone (p < 0.001). The resultant NCV value matched that for the high dose of vitamin E, although a significant deficit remained (6.5 + 0.5 %, p < 0.001) compared to the non-diabetic group. The combination gave results consistent with a simple addition of anti-oxidant effects. Thus, the 35.4 % protection by vitamin C superimposed on the 38.8 % protection provided by vitamin E would theoretically lead to an NCV value of 58.9 m 9 s -1 compared to the observed value of 59.6 + 0.3 m 9 s -1, which did not differ significantly. Sensory saphenous NCV (Fig. 1B) was reduced by 16.6 + 1.2 % (p < 0.001) after 1 month of diabetes. Vitamin C treatment provided partial protection (8.4 + 0.5 % deficit, p < 0.001 vs non-diabetic and untreated diabetic groups). With vitamin E, there was a dose-dependent prevention of sensory NCV deficits (p < 0.001), values for the lower-dose remaining depressed compared to the non-diabetic group (p < 0.01) whereas for the high dose they fell within the non-diabetic range. Combined vitamin C and low-dose vitamin E treatment gave the highest sensory NCV which was not significantly different from the non-diabetic group. As with motor NCV, the joint treatment effect on sensory NCV was comparable to expectations based on additivity of anti-oxidant potential. Thus, the 47.0 and 68.1%, protection afforded by vitamins C and E respectively combine to give a predicted sensory NCV of 60.0 m-s -I which is in good agreement with the observed value of 60.7 + 0.5 m. s -1. Under hypoxic conditions, in vitro, there was a markedly prolonged decline of sciatic nerve compound action potential amplitude with diabetes, which was true for all groups regardless of treatment. Thus, the duration of hypoxia necessary for an 80% amplitude reduction was elevated from 20.4+0.9rain in the non-diabetic group to 35.1+l.0min in the untreated diabetic group (p < 0.001). This was not significantly altered by vitamin C or vitamin E treatments alone. For the joint vitamin C and E treated group, 80 % conduction failure was achieved in 31.8 + 1.1 min which was less (p < 0.05) than for untreated diabetes while remaining markedly elevated compared to the non-diabetic group (t7 < 0.001). Within the treated and untreated diabetic groups there was a modest but statistically significant negative correlation between sciatic motor NCV as the dependent variable and 80 % conduction failure time as the independent variable (r = -0.363, p = 0.023). (approximately 80 %) was obtained with the highest dose used (1000 rag. kg -1 9 day -z) and doses less than 500 mg-kg -1 9 day -1 had a negligible effect on motor NCV.
The dose-response curves for vitamin C reversal of deficits in motor NCV to tibialis anterior muscle and sensory saphenous NCV are shown in Figure 2 . The highest degree of reversal was found with 50-150 mg. kg -1-day -1 treatment, approximately 35 % for motor and 45 % for sensory NCV (p < 0.001), similar to the level of protection afforded over the first month of diabetes (Fig. 1) . At the highest dose examined (500 rag. kg -1 9 day -1) there was a tendency for NCV to be reduced compared to intermediate doses, which was statistically significant for saphenous NCV (p = 0.0012, Mann-Whitney U-test, 150 mg-kg -I. day -1 vs 500 rag. kg -1. day-I). Figure 3 shows the dose-response curve for vitamin E prevention of motor NCV deficits. Maximum protection
Study 2: effects of vitamins C, E and fl-carotene on sciatic nerve blood flow and motor conduction velocity.
Motor NCVs for vitamins C (55.9+0.4 m-s -1, n = 12) and E (62.2_+ 0.6 m. s -z, n--9) treatments were elevated (p < 0.001) compared to untreated diabetes (51.2 + 0.6 m-s -1, n = 10), but remained reduced (p < 0.001 for vitamin C, p < 0.05 for vitamin E) compared to the non-diabetic group (64.1 + 0.4 m. s -1, n = 10), in agreement with data from the first study. The greatest protection (90.1 + 3.7 %, p < 0.001) was given by 13-carotene treatment; NCV (62.8 + 0.5 m. s -1, n = 11) was not significantly different from the non-diabetic group.
Endoneurial nutritive blood flow (Fig.4A) [29] , this would tend to exacerbate diabetic effects and minimize treatment effects on vasa nervorum. Blood pressure differences are taken into account when the data are expressed as vascular conductance (Fig. 4C) . The diabetic conductance deficit was 39.2 + 5.8 % (p < 0.001). Conductance tended to be supranormal in the vitamin E and I3-carotene treated groups, and this was statistically significant in the latter case (p < 0.05). Vitamin C treatment improved conductance by 27.1 + 4.1% (p<0.01), however it remained 22.7+2.5% (p < 0.05) lower than the non-diabetic group. Hydrogen clearance curves for peripheral nerve are generally composed of two components. A fast component arises due to clearance by large vessels (arterial, venous and arterio-venous flow) and is non-nutritive while a slow component represents capillary (nutritive) clearance [23, 24] . The composite value for both components gives an index of total (nutritive plus non-nutritive) endoneurial flow. Composite flow was reduced by 52.8 + 5.2 % (p < 0.001) after i month of diabetes (Fig. 5A) . This was partially prevented by vitamin E (62.7+ 17.6% protection, p < 0.01) whereas B-carotene and vitamin C had lesser effects which were not statistically significant compared to the untreated diabetic group, composite flow remaining reduced compared to the non-diabetic group (p < 0.001). When corrected for blood pressure differences, composite conductance (Fig.5B) was depressed by diabetes (46.9+ 6.0%, p<0.001) and in the vitamin C-treated group (34.5 + 5.7 %, p < 0.05). For vitamin E, conductance was elevated compared to untreated diabetes (p < 0.01), and was not significantly different from the value for the non-diabetic group. With ~-carotene treatment, conductance was not significantly different from diabetic or non-diabetic groups. There was a correlation between NCV (dependent variable) and nutritive blood flow (independent variable) for the treated diabetic rats (r=0.457, p = 0.015), but no significant correlation was found between NCV and composite flow (r=0.004, p = 0.983).
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Discussion
The data show that some natural anti-oxidants available in the diet can protect against the development of NCV and nutritive endoneurial blood flow deficits in experimental diabetes. This finding is in agreement with other intervention studies using free radical scavengers; NCV deficits were prevented by butylated hydroxytoluene [12] partially prevented but not corrected by glutathione [13] and both prevented and corrected by probucol [11] . In addition, probucol halted the development of reduced nutritive blood flow and endoneurial hypoxia [11] . The degree of NCV protection by vitamins C and E was greater for saphenous sensory than sciatic motor fibres, as noted for other treatments such as aldose reductase inhibition [30] .
The effects of vitamin C, E and [3-carotene were not equivalent, even taking dose differences into account. In particular, vitamin C provided fairly poor neuroprotection. One possible explanation may be that lipophilic scavengers, such as vitamin E or [3-carotene, are more effective than hydrophilic species, presumably because they may be present at high concentrations in cell membranes subjected to ROS attack. This argument may be compatible with the partial prevention and a lack of reversal of NCV deficits by the hydrophilic anti-oxidant, glutathione [13] . However, in preliminary experiments we have noted that the glutathione precursor, N-acetyl-L-cysteine provides a very high level of protection against NCV and blood flow defects in our model [31] , therefore, this view is unlikely to be correct. Another possible explanation relates to cellular uptake of vitamin C, which is reduced by both hyperglycaemia and hypoinsulinaemia [32]; an effect that might limit access to important intracellular sites of action. Vitamin C has been suggested to act via regeneration of a-tocopherol from the tocopheroxyl radical formed when vitamin E reacts with ROS [33] . However, it is not clear whether this effect, observed in vitro, also operates in vivo [34] . The NCV and blood flow data indirectly suggest that vitamin E regeneration is not a major action, as there was a large discrepancy between vitamin C and E effects. Diabetic rats, even without treatment, have a greater than normal vitamin E consumption because they are hyperphagic. This is reflected in tissue levels, including sciatic nerve where they are approximately doubled [15] . The dose of vitamin E needed to partially prevent NCV deficits was at least 100 times greater than the rats' usual dietary intake. Thus, even if vitamin C had efficiently regenerated all the available vitamin E that the rats normally consumed, there would still not have been enough to influence NCV, judging from the vitamin E dose-response curve. There was also little indication that vitamin E overwhelmed the action of vitamin C in the joint treatment group. In-stead effects of the two scavengers were additive for motor and sensory NCV, as if they were acting by independent complementary mechanisms or at different sites. This interaction appears to be relatively simple compared to joint treatment experiments using aldose reductase inhibitors and ~0-6 essential fatty acids where marked facilitatory effects have been observed [35] . Thus, vitamin C is likely to function as an anti-oxidant in its own right, presumably scavenging ROS in an aqueous environment, either in the circulation or intracellularly. The limited effect of vitamin C on NCV and blood flow, compared to other hydrophilic scavengers such as N-acetyl-L-cysteine [31] , could be due to its other role as a pro-oxidant in generating ROS by the process of auto-oxidation [17] . A dual anti-/pro-oxidant action may also explain the shape of the vitamin C dose-response curve, where the highest dose was less effective than intermediate doses against NCV deficits.
A previous study [15] showed that rearing diabetic rats on a vitamin E-deficient diet exacerbated increases in markers of oxidative stress (conjugated dienes and hydroperoxides) in neural tissues, the reduction in sciatic nerve glutatione content, and NCV deficits. However, the converse experiment, using a vitamin E-enriched diet, did not significantly alter conjugated dienes and hydroperoxides, reduced glutatione and NCV. The latter finding contrasts with the present data, although the lack of effect of vitamin E was likely to be because of the relatively low dose used (190 mg. kg -1 3 times per week, or 109 mg. kg -1. day -1) in that study. Thus, the dose-response curve (Fig.3) shows that little functional effect would be expected for doses of vitamin E below 250 rag-kg -1 -day -1. Presumably this would also be true for markers of oxidative stress and glutathione. It must be noted, however, that the short-term effects of anti-oxidant treatment appear to be primarily neurovascular, therefore, if technically feasible, measurement of these parameters in vasa nervorum rather than axons and Schwann cells would be of greater relevance.
Treatment with 13-carotene was at least as successful as vitamin E against NCV and nutritive blood flow abnormalities. As [3-carotene is not a chainbreaking anti-oxidant in the manner of vitamin E, but is more effective against excited singlet oxygen species [18] , this may suggest that more than one type of ROS is important for diabetic neural and neurovascular deficits. The degree of protection against nutritive blood flow deficits was roughly in line with effects on NCV for B-carotene and vitamins C and E. However, there was no correlation between NCV and composite flow. One reason why changes in composite flow may not correlate with NCV when using data pooled from different treatments is because they alter the pattern of endoneurial flow in different ways. Thus, ~-carotene had a greater effect on nutritive (84% increase) than composite (29% increase) flow (p = 0.0098, Wilcoxon signed rank test) whereas vitamin E caused similar increases of approximately 70 % for both measures. This suggests that [3-carotene had a more specific action favouring capillary flow, whereas vitamin E promoted a generalized flow increase in both large and small vessels. Other examples of flow pattern changes have been documented. Aldose reductase inhibitors and N-acetyl-L-cysteine caused diversion of blood from arterio-venous shunts to the endoneurial capillary bed [30, 31] , whereas for high-dose insulin, arterio-venous shunting increased to an extent that compromised nutritive flow, the result being endoneurial hypoxia in the absence of any reduction in composite flow [36] . Given the potential for treatments to alter the pattern of nerve perfusion, it is important to measure flow in the endoneurial capillary bed rather than relying on more general whole nerve flow estimates when assessing the potential mechanisms of action of pharmacological agents against NCV abnormalities. Thus, an increase in whole nerve laser-Doppler flux with vitamin E treatment has recently been reported [37] , in line with the hydrogen clearance measurements, however, it is unlikely that the laser-Doppler method would detect the more complex changes in endoneurial flow for agents such as [3-carotene.
The mechanisms underlying the decreased flow in diabetes, and the effects of free radical scavenger treatment, are not known in detail. However, it has been hypothesized that alterations in vascular endothelium result in a deficit in the production/release/ action of prostacyclin and NO as well as elevated synthesis of angiotensin II and endothelin i [6, 8, [38] [39] [40] . Thus, a "push-pull" system of reduced local vasodilation and increased vasoconstriction may operate to decrease blood flow. Diabetic NCV abnormalities can be mimicked in non-diabetic rats by joint cyclooxygenase/NO synthase inhibition [10] . Vitamin E treatment corrected an abnormal prostacyclin/thromboxane A 2 ratio in diabetic rats [4] . Agents such as evening primrose oil, which increase vasa nervorum prostacyclin synthesis [41] , also prevent NCV abnormalities, nutritive blood flow deficits, and endoneurial hypoxia [42] . Thus, one action of vitamin E, and perhaps other anti-oxidants, could be to prevent decreased vasa nervorum prostacyclin synthesis. Acute treatment with free radical scavengers improves in vitro endothelial NO release for large vessels from diabetic rats [43, 44] , and chronic treatment prevents the development of impaired endothelium-dependent relaxation (Archibald V, Cotter MA, Cameron NE, unpublished observations). Superoxide radicals neutralize NO, a reaction producing hydroxyl radicals that could damage the endothelium [45, 46] . Thus, it is plausible that anti-oxidants both protect vasa nervorum NO output and prevent endothelial damage. More widespread effects are also indicated; probucol treatment of diabetic rats prevented the elevation of plasma angiotensin converting enzyme concentration, a marker of both endothelial damage and increased activity in the local renin-angiotensin system [11] .
Vitamin E and C effects on resistance to hypoxic conduction failure were considerably smaller than for NCV. Hypoxic resistance reflects an adaptation to the hypoxic endoneurium, involving increased reliance on anaerobic energy metabolism [6, 24] . It also occurs in non-diabetic rats reared under hypoxic conditions or with chronic manipulations which reduce nerve blood flow [10, 47] . Vitamins E and C-mediated increases in nerve perfusion would partially reduce endoneurial hypoxia, however, this may not be sufficient to prevent hypoxic resistance, which is substantially less amenable than NCV to treatments that elevate blood flow [6] . In addition, hyperglycaemic exposure can independently stimulate nerve anaerobic metabolism [48] . Nerve function could also be adversely affected by "hyperglycaemic pseudohypoxia" caused by excessive flux through the second half of the polyol pathway which may promote an elevation in cell NADH/NAD ratio with widespread effects on intermediate metabolism [49] . However, it is unlikely that this putative mechanism can explain resistance to hypoxic conduction failure which is largely prevented in diabetic rats by using peripheral vasodilator or evening primrose oil treatments which cause greater increases in nerve perfusion [6, 21, 39, 42] than the anti-oxidants used in this study. In addition, partial reversal of hypoxic resistance was noted after 7 days of chronic electrical nerve stimulation [50] . These manipulations do not alter the level of hyperglycaemia or polyol pathway metabolism, therefore hypoxic resistance can be markedly reduced despite the presence of a diabetic level of hyperglycaemic pseudohypoxia. In addition, hypoxic resistance is a feature of experimental galactosaemia where flux is limited to the first half of the polyol pathway [24, 51] and pseudohypoxia would not be expected. The presence of hypoxic resistance in anti-oxidant-treated diabetic rats in this study is, therefore, consistent with an incomplete prevention of nerve perfusion and NCV deficits. A previous investigation using butylated hydroxytoluene, which gave better preservation of NCV than vitamins C or E, also showed a greater effect against hypoxic resistance [12] .
Direct and indirect evidence shows that diabetic patients with neuropathy have reduced nerve blood flow and endoneurial hypoxia [52] [53] [54] . Thus, free radical scavenger treatment might theoretically be suitable. One rather disappointing finding is that pharmacological rather than physiological concentrations of natural anti-oxidants are necessary to protect neurovascular function in diabetic rats. This may in part be due to the high levels of hyperglycaemia in experimental diabetes. The processes of advanced glycation and glucose auto-oxidation are thought to be important sources of ROS [17] , therefore, free radical generation is likely to be greater in experimental models than in patients with relatively well-controlled diabetes. Thus, anti-oxidants may be effective at lower doses in patients and the magnitude of general cardiovascular effects of acute treatment [5] encourages the view that this therapeutic approach merits examination in clinical trials against neuropathy.
